Active Ingredient(s): Alglucerase
FDA Approved: * April 5, 1991
Pharm Company: * GENZYME
Category: Enzymes

Alglucerase was a biopharmaceutical drug for the treatment of Gaucher's disease. It was a modified form of human β-glucocerebrosidase enzyme, where the non-reducing ends of the oligosaccharide chains have been terminated with mannose residues.[1] Ceredase is the trade name of a citrate buffered solution of alglucerase that was manufactured by Genzyme Corporation from human placental tissue.[1] It is given intravenously in the treatment of Type 1 Gaucher'... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.